Nucleic acid regulatory elements for constitutive gene expression and methods of use

A NARE comprising:

• (i) a sequence that is at least 90% identical to any one of SEQ ID NOs:381, 384, 392, 393, 394, 395, 396, 397, 400, or 401;
• (ii) a sequence that is at least 90% identical to SEQ ID NO:
• 334 or SEQ ID NO:
• 342;
• and (iii) a sequence that is at least 90% identical to SEQ ID NO:426.

A NARE comprising:

• (i) any one of SEQ ID NOs:381, 384, 392, 393, 394, 395, 396, 397, 400, or 401;
• and (ii) SEQ ID NO:
• 334 or SEQ ID NO:
• 342;
• and (iii) SEQ ID NO:426.

A NARE comprising:

• (i) a sequence that is at least 90% identical to any one of SEQ ID NOs:344-349, or 498;
• (ii) a sequence that is at least 90% identical to SEQ ID NO:334 or SEQ ID NO:
• 342;
• (iii) a sequence that is at least 90% identical to any one of SEQ ID NOs:302-318, 320-322, 324-327, 331, 332, or 487, (iv) optionally, SEQ ID NO:333;
• and (v) optionally, a sequence that is at least 90% identical to SEQ ID NO:319.

A NARE comprising:

• (i) a sequence that is at least 90% identical to any one of SEQ ID NOs:344-349, or 498;
• (ii) a sequence that is at least 90% identical to any one of SEQ ID NOs:351-356, 499, or 500;
• (iii) a sequence that is at least 90% identical to any one of SEQ ID NOs:
• 200, 370, 417-420, 502, 441, 482-485, 489, or 491-496;
• and (iv) optionally, a sequence that is at least 90% identical to any one of SEQ ID NOs:444, 452, or 488;
• (v) optionally, a sequence that is at least 90% identical to SEQ ID NO:402;
• and (vi) optionally, SEQ ID NO:433.

A NARE comprising:

• (i) a sequence that is at least 90% identical to any one of SEQ ID NOs:344-349, or 498;
• (ii) a sequence that is at least 90% identical to SEQ ID NO:335;
• and (iii) a sequence that is at least 90% identical to any one of SEQ ID NOs:
• 294, 295, 296, 299, 323, 328, 329, 330, 407, 501, 430, 431, 503, 434, or 504;
• and (iv) optionally, a sequence that is at least 90% identical to SEQ ID NO:444.

A NARE comprising:

• (i) a sequence that is at least 90% identical to any one of SEQ ID NOs:374-376;
• (ii) optionally, a sequence that is at least 90% identical to any one of SEQ ID NOs:344-349, 498 or 393;
• (iii) a sequence that is at least 90% identical to any one of SEQ ID NOs:93-98, 103, 109, 128-136, 195-198, 201, 284, 285, 301, 362, 371, 373, 403-406, 408-410, 412, 417-420, 502, 427, 453-456, 460-474, 486, or 490;
• and (iv) optionally, a sequence that is at least 90% identical to SEQ ID NOs:443 or 448.

A NARE comprising:

• (i) a sequence that is at least 90% identical to SEQ ID NOs:478 or 479;
• (ii) a sequence that is at least 90% identical to SEQ ID NO:350;
• (iii) a sequence that is at least 90% identical to any one of SEQ ID NOs:351-356, 499, or 500;
• and (iv) a sequence that is at least 90% identical to any one of SEQ ID NOs:361, 421, 422, 423, 428, 444, or 480.